Navigation Links
Crucial gene activator in slow-killing parasite identified
Date:1/5/2012

In the complicated life cycle of ancient flatworms that cause schistosomiasis, Case Western Reserve University researchers have identified a gene activator crucial to development of the parasites within humans a potential target for a vaccine.

A description of the activator, which turns on rapid growth, is in the online journal PLoS Neglected Tropical Diseases.

Schistosomiasis, which causes organ damage and failure, afflicts more than 200 million people worldwide, killing 280,000 annually. Another 400 million people are at risk for the disease.

For decades, a single drug, praziquantel, has been used to kill the worms, and scientists are concerned the drug may become useless. The worms, called schistosomes, have shown they can develop resistance to praziquantel in the lab and there is currently no other drug to treat the disease.

Beyond that concern, the lack of a vaccine leaves human hosts in a cycle of their own: becoming infected, taking praziquantel, becoming reinfected - multiple times - due to the prevalence and ease of contracting the parasite in rivers and ponds in Asia, Africa and South America. Repeated exposure can add up to illness and death.

"This is really a disease of poor people," said Emmitt Jolly, professor of biology at Case Western Reserve and senior author of the paper. "The strategy to combat the disease cannot be expensive."

Jolly and John Milligan, a technician in Jolly's lab and lead author, spent two years studying, identifying and characterizing the protein, and gene activator, myocyte enhancer factor 2, commonly referred to at Mef2, in the flatworm's life cycle.

Depending on the phase of development, the schistosome lives in snails, in freshwater or in humans. From the snail, it becomes a tiny free swimmer that penetrates human skin. The parasite enters blood vessels and feeds on blood cells.

Sexually mature schistosomes congregate in blood vessels in a part of the abdomen called the mesentery. They mate and lay 300 to 1,000 eggs per day that migrate through the liver. About half the eggs are passed outside with urine and feces, depending on the species, and half get stuck in the body.

Upon reaching fresh water, the half excreted hatch into free swimmers that enter and grow in snails.

The half that remain in the body build up and cause an immune response. The eggs become encapsulated in granulomas, immune cells that wall off the foreign material. The result is significant organ damage, particularly in the liver, spleen, and intestine, but also other organs. Schistosomes can live and lay eggs for decades, the build-up of the granulomas slowly sickening and killing the host.

Mef2 is found in plants and yeast on up to humans. The activator is essential to muscle, nerve and bone development in humans, but how it works in flatworms was unknown.

Jolly and Milligan found, by homology, the protein appeared similar to Mef2 in yeast. Mef2 has two parts that act independently: one part binds to DNA, the second part activates gene expression.

When the researchers combined the schistosome gene activator with the DNA binder of yeast, the combination switched on the same yeast gene as the pure yeast gene activator.

They found that in the Schistosome, Mef2 expression is turned up right after the swimmer enters the human host. During this time, the parasites grow from 100 micrometers in length to 10 to 16-millimeter worms.

Praziquantel is most effective when schistosomes start producing eggs inside human hosts. A vaccine could prevent the parasite from reaching sexual maturity and laying eggs inside of hosts thereby preventing schistosomiasis, the researchers say.

Although Mef2 is present in humans, the portion of schistosome Mef2 that switches on gene activity is so different from human Mef2 that "We can target that part, and not affect the host," Jolly said.

Milligan and Jolly are working with other researchers to further understand schistosome Mef2 and are hopeful the work will lead to an alternative to praziquantel or a complimentary drug.


'/>"/>
Contact: Kevin Mayhood
kevin.mayhood@case.edu
216-368-4442
Case Western Reserve University
Source:Eurekalert

Related biology news :

1. Hidden infections crucial to understanding, controlling disease outbreaks
2. Mayo researchers identify dangerous two-faced protein crucial to breast cancer spread and growth
3. In lung cancer, silencing one crucial gene disrupts normal functioning of genome
4. Simplicity is crucial to design optimization at nanoscale
5. Caffeic acid inhibits colitis in a mouse model -- is a drug-metabolizing gene crucial?
6. For HIV-infected children, quality of caregiver relationship is crucial
7. Crucial differences found among Latino populations facing heart disease risks
8. Vitamin D crucial to activating immune defenses
9. Payment Default Risks Remain a Crucial Issue for Businesses Across Europe
10. Nailing down a crucial plant signaling system
11. Blocking crucial molecule could help treat multiple sclerosis, Jefferson neuroscientists say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... HAMPTON, Va. , Aug. 15 2017   ivWatch LLC ... effectiveness of intravenous (IV) therapy, today announced receipt of its ISO ... (QMS) developed by the International Organization for Standardization (ISO┬«). ... ivWatch Model 400 Continuous Monitoring device for ... "This ...
(Date:5/23/2017)... 2017  Hunova, the first robotic gym for the rehabilitation and functional ... in Genoa, Italy . The first 30 robots will ... USA . The technology was developed and patented at ... IIT spin-off Movendo Technology thanks to a 10 million euro investment from ... click: ...
(Date:4/19/2017)... New York , April 19, 2017 ... competitive, as its vendor landscape is marked by the ... the market is however held by five major players ... Safran. Together these companies accounted for nearly 61% of ... of the leading companies in the global military biometrics ...
Breaking Biology News(10 mins):
(Date:9/20/2017)... Palo Alto, CA (PRWEB) , ... September 20, ... ... and public interest organization focused on molecular manufacturing and other transformative technologies, announced ... categories, one for Experiment and the other for Theory in nanotechnology/molecular manufacturing. , ...
(Date:9/19/2017)... ... 19, 2017 , ... Participants of this educational webinar will ... Along with the advantages and disadvantages of ductless, filtered fume hoods, they will ... laboratory. , Attendees will learn from an industry expert about the different types ...
(Date:9/19/2017)... ... September 19, 2017 , ... The new and improved Oakton® pocket ... testers even stand upright with a new cap design that is versatile, functional and ... field who need to test water quality. , The Oakton pocket testers have many ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... is pleased to announce the recipients of its 2017 Science Student Award. The ... leadership qualities, and involvement with community service defray the costs of obtaining their ...
Breaking Biology Technology: